Question 1

What is Tscan Therapeutics Inc (TCRX) stock price today?

Accepted Answer

Tscan Therapeutics Inc (TCRX) currently trades at $1.15 per share. The stock has a market capitalization of $75.73M and a P/E ratio of —x.

Question 2

Is TCRX stock a buy, sell, or hold in 2026?

Accepted Answer

Based on WallStSmart's proprietary analysis, Tscan Therapeutics Inc has a Smart Value Score of 40/100 (Grade D), resulting in a "Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

Question 3

What is Tscan Therapeutics Inc's revenue and earnings?

Accepted Answer

Tscan Therapeutics Inc has trailing twelve-month (TTM) revenue of $10.32M with profit margins of 0.00%. Earnings per share (EPS) is $-1.00.

Question 4

Is TCRX stock overvalued or undervalued?

Accepted Answer

Based on our DCF model, Tscan Therapeutics Inc's intrinsic value is $0.79, representing a margin of safety of -23.09%. The stock currently trades at a P/E of —x.

Metric	2022	2023	2024	2025	TTM
Revenue	$13.54M	$21.05M	$2.82M	$10.32M	$10.32M
Net income	$-66.22M	$-89.22M	$-127.50M	$-129.77M	$-22.98M
EPS	—	—	—	—	$-1.00
Free cash flow	$-70.73M	$-64.50M	$-114.65M	$-139.73M	$-32.17M
Profit margin	-489.26%	-423.86%	-4,527.66%	-1,256.81%	—

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
TCRX	$75.73M	40	5.3	2.5	4.0	5.0	-23.09%	Hold
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Tscan Therapeutics Inc

WallStSmart proprietary scores

Price targets

Price chart

X-Ray snapshot

Key financials

Peer comparison

Smart narrative

Frequently asked questions

Company info

Quick metrics

Performance

Compare